Jonathan Harris, Nutter McClennen & Fish LLP Photo

Jonathan A. Harris

Partner / Boston


Jonathan Harris is a business-minded life sciences patent attorney and MBA who helps clients understand and leverage IP. Jonathan has 25 years of experience in every facet of patent practice. He has drafted complex patent licenses and international collaboration agreements, served as first chair trial counsel in numerous patent actions, led IP diligence teams, and prepared and prosecuted hundreds of patent applications.

Jonathan’s experience in pharmaceuticals is particularly extensive. He has negotiated and drafted a variety of IP-related agreements in the area, everything from strategic alliances and manufacture and supply agreements to clinical trial agreements. He has served as lead trial counsel in multiple Paragraph IV matters on behalf of some of the world’s largest pharmaceutical companies. Having worked for innovators and generics alike, his unique and comprehensive background allows him to see around corners and effectively position cases for trial. Jonathan also works regularly with emergent life science companies to help position their patent estates to raise capital and prepare for successful exit.

According to clients, Jonathan is “adept at translating complex technical subjects into English” and “great in the courtroom, articulate and quick on his feet.”

Jonathan is a partner in Nutter’s IP Department and a member of the firm’s Life Sciences group.

Notable Experience and Client Impact

Life Science Agreements

  • Patent licenses, collaborations, and commercial agreements: bioMerieux(clinical trial agreements); CoRISMA(medical device) in collaboration with China Grand; Insud Pharma (commercial agreements); Notable (cancer therapeutic) in worldwide collaboration with OncoHeroes; VeraDermics (derm therapeutics) in multiple collaborations and manufacturing agreements
  • University licenses: Cellinfinity(cancer therapeutic) with Ivy League university; Insud Pharma (diagnostic biomarkers)with Canadian university; LeptoX with Ivy League University; VeraDermics with Ivy League university

Patent Litigation

  • Analyze patent portfolios in preparation for Paragraph IV Notice Letters and litigation
  • Served as first chair trial counsel in numerous Paragraph IV patent actions: Cialis® ($2.3 billion annual sales); Lyrica® ($5.1 billion annual sales); Oxycontin® ($1.8 billion annual sales), Reclast®/Zometa® ($1.5 billion annual sales), and Ritalin®/Focalin® ($450 million annual sales)

IP Due Diligence

  • Oversee IP diligence on small and large molecule therapeutics: Abraxane® ($1B annual sales), Eliquis® ($8B annual sales), Suboxone® ($1.1B annual sales), Tysabri® ($1.9B annual sales), and clinical trial assets in Phase I, II and III.   

Patent Preparation, Prosecution, Counseling

  • Prepare and prosecute over 200 patent applications. Retained to oversee independent law firm’s prosecution of Orange Book listable patents. Assess patentability, conduct freedom to operate, and prepare patent opinions.

News & Insights



  • The Best Lawyers in America, 2018-2024
  • IAM Patent 1000, 2021

Education & Admissions


University of Connecticut School of Law, J.D., cum laude
University of Connecticut School of Business, MBA, cum laude
Duke University, B.S., Biology


  • Connecticut
  • Massachusetts
  • U.S. Patent and Trademark Office

What Clients Say

  • “Adept at translating complex technical subjects into English.”
  • “Excellent patent analyst with an encyclopedic knowledge of Federal Circuit case law.”
  • “Great in the courtroom. Articulate and quick on his feet.”


  • The Best Lawyers in America, 2018-2024
  • IAM Patent 1000, 2021
Back to Page